References
- BanysMHartkopADKrawczykNDormancy in breast cancerBreast Cancer: Targets Ther20124183191
- BraunSAuerDMarthCThe prognostic impact of bone marrow micrometastases in women with breast cancerCancer Invest200927659860319557580
- LimPKBlissSAPatelSAGap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cellsCancer Res20117151550156021343399
- KawadaKTaketoMMSignificance and mechanism of lymph node metastasis in cancer progressionCancer Res20117141214121821212413
- GrecoSJPatelSABryanMPlinerLFBanerjeeDRameshwarPAMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cellsAm J Cancer Res20111670171522016821
- PatelSAMeyerJRGrecoSJCorcoranKEBryanMRameshwarPMesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-betaJ Immunol2010184105885589420382885
- SunXLXuZMKEYQMolecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cellsCancer Lett2011312216817721924825
- GrisendiGBussolariRVeronesiEUnderstanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the MesenkillersAm J Cancer Res20111678780522016827